We are here to help. Visit our Coronavirus (COVID-19) Task Force Resource Center for the latest developments and legal updates.

We are here to help. Visit our Coronavirus (COVID-19) Task Force Resource Center for the latest developments and legal updates.

Morris Manning & Martin, LLP

Ping Wang, M.D.

Ping Wang, M.D.

Partner
Phone: 202.971.4234
Fax: 202.408.5146
[email protected]
vCard

IAM 1000

Dr. Ping Wang is the leader of the firm’s D.C. Intellectual Property Practice. Her practice focuses on all aspects of intellectual property, including patent prosecution, inter partes review, post grant review, interference practice, counseling and opinions regarding patentability, patent invalidity, freedom-to-operate, infringement, design around and diligence work in connection with mergers and acquisitions in the biotechnology industry. Dr. Wang also handles patent interferences, patent infringement and other litigation matters, licensing negotiations, technology and academic agreements, acquisitions of capital for entrepreneurs, start-ups and institutions.

For eight consecutive years, Dr. Wang has been named among the world’s leading patent practitioners in IAM Patent 1000, the top worldwide guide to leading patent professionals and firms. Dr. Wang has extensive experience securing broad-scope protection for start-ups, universities, middle-sized and large corporations globally, as well as negotiating and handling business transactions on clients' behalf. She has particular experience in business negotiations and transactions between the United States and China. She is knowledgeable about all aspects of life sciences, and has particular experience in pharmaceuticals, biotechnology, chemical/organic chemistry, medical devices and artificial intelligence.

Dr. Wang has played a lead role in inter partes review – which is strengthened by her extensive prior patent interference experience.  She has also provided clients assistance in commercialization and securing funding, with particular experience in China.  Dr. Wang has substantial experience in due diligence work in connection with mergers and acquisitions in the biotechnology industry.  Dr. Wang has well-established relationships throughout the world which enables swifter patent prosecution outside the United States.  She is business-oriented and gives detailed attention to developing client concepts into complex and complete applications.

She was the recipient of the Elliot Stellar Award from the Philadelphia Chapter, Society for Neuroscience, and the Lapides Award given by the American Urological Society.

Accolades

  • Managing Intellectual Property, IP Stars, Patent Star 2020
  • IAM Global Leaders, Patent Prosecution, 2020
  • IAM Patent 1000, Patent Prosecution, 2012 - 2019
  • IAM Patent 1000, Transactions, 2015 - 2019
  • National Law Journal, Intellectual Property Trailblazer, March 2019
  • Profiled as one of the leading Patents: Licensing, and Patents: Prosecution lawyers in the United States, The US Legal 500, 2017
  • Elliot Stellar Award from the Philadelphia Chapter, Society for Neuroscience, 1994
  • Lapides Award from the American Urological Society, 1994

Membership

  • American Bar Association
  • American Intellectual Property Law Association
  • American Health Law Association
  • American International Law Association
  • Member, American Intellectual Property Law Association, Interference Committee, Biotechnology Committee, and Licensing Committee
  • United States Patent and Trademark Office, Biotechnology, Chemical, and Pharmaceutical Partnership
  • Society for Neuroscience
  • International Brain Research Organization